Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

The Role of Multimodality Imaging in Left Atrial Appendage Closure

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of the present prospective, randomized single-centre study is to examine the success rate, safety, overall preoperative and operative burden and long-time outcome of percutaneous left atrial appendage closure procedures after unimodal and multimodal preprocedural imaging. According to the investigators' primary hypothesis, simple, unimodal preprocedural imaging does not increase procedural burden of LAAC (total radiation dose, procedure time, fluoroscopy time, contrast amount). The investigators assume, that the success rate and safety of LAAC procedures is not reduced using unimodal preoperative imaging. Regarding to postoperative imaging, the investigators aim to compare the sensitivity of different imaging techniques in detecting postoperative complications. We assume, that multimodal imaging technique increases the accuracy and sensitivity of the detection of postoperative complications (PDL, device thrombi).

Who May Be Eligible (Plain English)

Who May Qualify: - Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025 - Age above 18 years - willing to sign a consent form - Legal capacity Who Should NOT Join This Trial: - Age under 18 years - Pregnancy - Incapacitation - Absence of consent - Esophageal stenosis or diverticulum - Active esophageal bleeding - CT-contrast agent allergy - Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2) - Appendage thrombus (mobile/with significant embolic risk) - Life expectancy shorter than 12 months - Active infection - Significant mitral valve stenosis - Mechanical heart valve - Open heart surgery is indicated Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025 * Age above 18 years * Informed consent * Legal capacity Exclusion Criteria: * Age under 18 years * Pregnancy * Incapacitation * Absence of consent * Esophageal stenosis or diverticulum * Active esophageal bleeding * CT-contrast agent allergy * Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2) * Appendage thrombus (mobile/with significant embolic risk) * Life expectancy shorter than 12 months * Active infection * Significant mitral valve stenosis * Mechanical heart valve * Open heart surgery is indicated

Treatments Being Tested

DIAGNOSTIC_TEST

Multimodal imaging

Preoperative 2D/3D TOE and MDCT, operative 2D/3D TOE and fluoroscopy/angiography, postoperative 2D/3D TOE and MDCT

DIAGNOSTIC_TEST

Standard imaging

Preoperative MDCT, operative 2D/3D TOE and fluoroscopy/angiography, postoperative 2D/3D TOE and MDCT

Locations (1)

Hungarian Institute of Cardiology (Gottsegen National Cardiovascular Center)
Budapest, Hungary